ICON plc (ADR) (NASDAQ:ICLR)

CAPS Rating: 3 out of 5

The Company is a contract research organization, providing clinical research and development services on a global basis to the pharmaceutical, biotechnology and medical device industries.

Recs

0
Player Avatar TrackMasterTrack (< 20) Submitted: 5/9/2008 11:24:43 PM : Outperform Start Price: $36.50 ICLR Score: -38.30

health care is due to rally

Featured Broker Partners


Advertisement